Minerva Neurosciences | NERV - 매출원가





매출원가 변화 날짜
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Adma Biologics USD 50.4M 8.24M 2025-12
ALKERMES USD 73.25M 27.04M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Cipla INR 26.32B 2.79B 2026-03
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 3.54M 1.89M 2025-12
CSL USD 3.87B 2.08B 2025-12
Eli Lilly USD 3.58B 205M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Grifols EUR 1.51B 184.45M 2025-12
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
J&J USD 8.07B 103M 2026-03
Merck USD 2.94B 380M 2026-03
Minerva Neurosciences 386K 31K 2024-06
Neurocrine Biosciences USD 13.8M 3.8M 2026-03
Novartis USD 3.46B 83M 2026-03
Novavax USD 22.1M 608K 2025-12
Pfizer USD 4.59B 1.7B 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Takeda JPY 560.54B 159.39B 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12